Peptide | Moderate Risk

Melanotan II

What to know about Melanotan II: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

Melanotan II is classified as Moderate risk (4 risk points) by AllMeds. NOT TGA registered. TGA has issued safety warnings. Cardiovascular and melanoma risks.

Key Takeaways

  • Risk level: Moderate (4 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) Unscheduled Not PBS listed

Risk Profile

Risk Level Moderate
Risk Points 4
CNS Depressant No
Respiratory Risk No

NOT TGA registered. TGA has issued safety warnings. Cardiovascular and melanoma risks.

How Melanotan II is regulated

Melanotan II is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as Unscheduled under the Therapeutic Goods Administration (TGA).

Clinical Evidence

  • TGA Safety Advisory: Melanotan-I and Melanotan-II - TGA (2020)

    TGA warns Melanotan products are not approved in Australia. Reports of serious side effects including cardiovascular events, nausea, and changes to moles that could mask melanoma detection.

    Official TGA safety warning — highly authoritative

  • FDA Warning on Melanotan Products - US FDA (2019)

    FDA has warned consumers not to use Melanotan products. Not approved for any use. Concerns about melanoma risk.

    Federal regulatory authority

  • The dark side of tanning injections — ABC Investigations - ABC News Australia (2022)

    Investigative reporting on Melanotan II use in Australia. Interviews with dermatologists warning about melanoma masking.

    National broadcaster investigation

Check this medication against your full medication list

Run a full risk assessment including Melanotan II interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.